首页|双配体修饰白蛋白-槲皮素纳米递药系统的制备及对卵巢癌SKOV3细胞的影响

双配体修饰白蛋白-槲皮素纳米递药系统的制备及对卵巢癌SKOV3细胞的影响

扫码查看
目的 制备双配体修饰白蛋白-槲皮素纳米递药系统(QUE@TAT-PEG-HSANPs),并观察其对卵巢癌SKOV3细胞的影响.方法 制备QUE@TAT-PEG-HSANPs,并用透射电镜观察纳米颗粒形态;MTT法检测QUE@TAT-PEG-HSA细胞毒性;观察QUE@TAT-PEG-HSA的癌细胞摄取及组织分布情况;流式细胞仪检测SKOV3细胞凋亡情况;建立卵巢癌移植瘤动物模型,H-E染色观察卵巢癌组织病理变化;TUNEL染色检测卵巢癌肿瘤细胞凋亡程度;Western blot检测卵巢癌细胞和组织中凋亡相关蛋白半胱氨酸蛋白酶-3(Caspase-3)、Bcl-2相关X蛋白(Bax)和B细胞淋巴瘤因子2(Bcl-2)及卵巢癌肿瘤酪氨酸3-单加氧酶-色氨酸5-单加氧酶活化蛋白(YWHAZ)/β-连环蛋白(β-catenin)轴相关蛋白表达.结果 QUE@TAT-PEG-HSA纳米颗粒紧密排列,大小均匀,呈圆球形,表面光滑,分散性良好,其对SKOV3细胞抑制率呈浓度依赖性上升;SKOV3细胞及卵巢癌组织FITC-QUE@TAT-PEG-HSA荧光强度随时间推移逐渐增强;QUE@TAT-PEG-HSANPs处理SKOV3细胞的细胞凋亡率、Bax、Caspase-3表达升高,Bcl-2表达降低(P<0.05);裸鼠移植瘤实验结果显示,QUE、QUE@HSA、QUE@TAT-PEG-HSA处理卵巢癌组织细胞均出现坏死凋亡现象增多,核质浓缩,核固缩溶解现象,卵巢癌组织细胞凋亡率、Bax、Caspase-3表达升高,Bcl-2、YWHAZ、β-catenin表达降低,其中QUE@TAT-PEG-HSA最为明显(P<0.05).结论 QUE@TAT-PEG-HSANPs可促进卵巢癌组织细胞凋亡,抑制肿瘤生长,其作用机制可能与抑制YWHAZ/β-catenin轴有关.
Preparation of dual ligand modified albumin quercetin nanodrug delivery system and its effect on ovarian cancer SKOV3 cells
Objective To prepare dual ligand modified albumin quercetin nanodrug delivery systems(QUE@TAT-PEG-HSANPs),and to observe its effect on ovarian cancer SKOV3 cells.Methods QUE@TAT-PEG-HSANPs was pre-pared,transmission electron microscopy was applied to observe the morphology of nanoparticles.MTT method was applied to detect the cytotoxicity of QUE@TAT-PEG-HSA cells.The uptake of cancer cells and tissue distribution of QUE@TAT-PEG-HSA were observed.Flow cytometry was applied to detect SKOV3 cell apoptosis.An animal model of ovarian cancer transplantation was established,H-E staining was applied to observe the pathological changes of ovarian cancer tissue.TUNEL staining was applied to detect the degree of apoptosis in ovarian cancer tumor cells.Western blot was applied to detect the expression of apoptosis related proteins Caspase-3,Bax,and Bcl-2 in ovarian cancer cells and tissues,and YWHAZ/β-catenin axis related proteins in ovarian cancer tumors.Results QUE@TAT-PEG-HSA nanoparticles are closely arranged,uniform in size,round in shape,smooth in surface and good in dispersion,and their inhibition rate on SKOV3 cells increases in a concentration-dependent manner.The fluorescence intensity of FITC-QUE@TAT-PEG-HSA in SKOV3 cells and ovarian cancer tissues increased gradually over time.The apoptosis rate of SKOV3 cells and expression of Bax and Caspase-3 treated with QUE@TAT-PEG-HSANPs increased,while the expression of Bcl-2 decreased(P<0.05).The results of tumor transplantation experiment in nude mice showed that QUE,QUE@HSA and QUE@TAT-PEG-HSA treated ovarian cancer tissue cells showed increased necrosis and apoptosis,nucleocytoplasmic concentration and nucleolysis,and increased apop-tosis rate,Bax and Caspase-3 expression.The expressions of Bcl-2,YWHAZ and β-catenin were decreased,and QUE@TAT-PEG-HSA was the most obvious(P<0.05).Conclusion QUE@TAT-PEG-HSANPs can promote apoptosis of ovarian cancer tissue cells and inhibit tumor growth,and its mechanism of action may be related to the inhibition of the YWHAZ/β-catenin axis.

dual ligand modified albumin quercetin nanodrug delivery systems(QUE@TAT-PEG-HSANPs)ovarian cancerSKOV3 cells

周晶、崔建荣、魏晓燕、姚海荣

展开 >

河北省沧州中西医结合医院康复院区体检中心,河北沧州 061000

沧县医院产科,河北沧州 061000

沧州市中心医院妇三科,河北沧州 061000

双配体修饰白蛋白-槲皮素纳米递药系统 卵巢癌 SKOV3细胞

河北省2024年度医学科学研究课题计划

20240733

2024

中国优生与遗传杂志
中国优生科学协会

中国优生与遗传杂志

CSTPCD
影响因子:0.527
ISSN:1006-9534
年,卷(期):2024.32(6)